Literature DB >> 33660096

Cannabis Legalization and College Mental Health.

Ludmila De Faria1, Lillian Mezey2, Aaron Winkler3.   

Abstract

PURPOSE OF REVIEW: To assess how the changing landscape of marijuana use affects the developing brain and mental health of college students. RECENT
FINDINGS: Legalization of cannabis may facilitate use in the college population, with 38% of college students, whose brains are still maturing, regularly using marijuana products. Earlier and increased use, higher potency, pre-existing issues, and genetic predispositions increase negative outcomes by precipitating or worsening mental illness and ultimately impacting academic success. In the USA, the sharpest increase in cannabis users following legalization has been in the college age population (18-25 years of age). This population is especially vulnerable to the negative impacts and risks associated with cannabis use, including risk for the onset of major psychiatric illness. College mental health practitioners should remain informed about health effects of cannabis use, assess patient use on a regular basis, provide education and be familiar with interventions to reduce harm.

Entities:  

Keywords:  Cannabis use; Cannabis use disorder; Cannabis-induced psychosis; College mental health; College students; Decriminalization; Legalization; Provider education

Year:  2021        PMID: 33660096     DOI: 10.1007/s11920-021-01231-1

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  10 in total

Review 1.  Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives.

Authors:  Simone Tambaro; Marco Bortolato
Journal:  Recent Pat CNS Drug Discov       Date:  2012-04-01

Review 2.  Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?

Authors:  Jasmine Turna; Beth Patterson; Michael Van Ameringen
Journal:  Depress Anxiety       Date:  2017-06-21       Impact factor: 6.505

3.  Development and evaluation of the Marijuana Reduction Strategies Self-Efficacy Scale.

Authors:  Alan K Davis; Lawrence A Osborn; Jaclyn Leith; Harold Rosenberg; Lisham Ashrafioun; Anna Hawley; Erin E Bannon; Samantha Jesse; Shane Kraus; Elizabeth Kryszak; Nicole Cross; Victoria Carhart; Kyoung-deok Baik
Journal:  Psychol Addict Behav       Date:  2014-06

4.  Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis.

Authors:  Marie Stefanie Kejser Starzer; Merete Nordentoft; Carsten Hjorthøj
Journal:  Am J Psychiatry       Date:  2017-11-28       Impact factor: 18.112

5.  Marijuana and Madness: Associations Between Cannabinoids and Psychosis.

Authors:  Mohini Ranganathan; Patrick D Skosnik; Deepak Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2016-04-01       Impact factor: 13.382

6.  Cannabis induced psychosis and subsequent psychiatric disorders.

Authors:  Dharav Shah; Prabhat Chand; Mrunal Bandawar; Vivek Benegal; Pratima Murthy
Journal:  Asian J Psychiatr       Date:  2017-10-16

Review 7.  The effects of cannabinoid administration on sleep: a systematic review of human studies.

Authors:  Peter J Gates; Lucy Albertella; Jan Copeland
Journal:  Sleep Med Rev       Date:  2014-03-07       Impact factor: 11.609

8.  Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial.

Authors:  Ruth E Cooper; Emma Williams; Seth Seegobin; Charlotte Tye; Jonna Kuntsi; Philip Asherson
Journal:  Eur Neuropsychopharmacol       Date:  2017-05-30       Impact factor: 4.600

Review 9.  Association Between Cannabis and Psychosis: Epidemiologic Evidence.

Authors:  Suzanne H Gage; Matthew Hickman; Stanley Zammit
Journal:  Biol Psychiatry       Date:  2015-08-12       Impact factor: 13.382

Review 10.  Cannabis Addiction and the Brain: a Review.

Authors:  Amna Zehra; Jamie Burns; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  J Neuroimmune Pharmacol       Date:  2018-03-19       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.